Development status: Approved, off-patent

Mechanism of Action/Target pathogen: Nitroimidazoles are prodrugs which are reduced in vivo to give radical species that are toxic to cells. The exact details of its mode of action remain unclear and may vary among species.

Additional information: Isomer of a natural producht azomycin produced by streptomyces. Mainly used for protozoal infections and Gram-negative anaerobe bacteria